These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 8434623

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Second-trimester maternal serum screening for Down syndrome in in vitro fertilization pregnancies.
    Rice JD, McIntosh SF, Halstead AC.
    Prenat Diagn; 2005 Mar; 25(3):234-8. PubMed ID: 15791658
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Periodic health examination, 1996 update: 1. Prenatal screening for and diagnosis of Down syndrome. Canadian Task Force on the Periodic Health Examination.
    Dick PT.
    CMAJ; 1996 Feb 15; 154(4):465-79. PubMed ID: 8630836
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Maternal serum superoxide dismutase (SOD): a possible marker for screening Down syndrome affected pregnancies.
    Ognibene A, Ciuti R, Tozzi P, Messeri G.
    Prenat Diagn; 1999 Nov 15; 19(11):1058-60. PubMed ID: 10589060
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Low serum alpha-fetoprotein level and sex chromosome monosomy.
    Winston YE, Horger EO, Van Dorsten JP.
    Am J Obstet Gynecol; 1988 Jul 15; 159(1):186-7. PubMed ID: 2456014
    [Abstract] [Full Text] [Related]

  • 52. Abnormal maternal serum alpha fetoprotein and pregnancy outcome.
    Zarzour SJ, Gabert HA, Diket AL, St Amant M, Miller JM.
    J Matern Fetal Med; 1998 Jul 15; 7(6):304-7. PubMed ID: 9848697
    [Abstract] [Full Text] [Related]

  • 53. [Unusual behavior of serum markers in risk evaluation for trisomy 21].
    Guibaud S, Boisson C, Chambon V, Simplot A.
    Ann Biol Clin (Paris); 1998 Jul 15; 56(4):439-44. PubMed ID: 9754279
    [Abstract] [Full Text] [Related]

  • 54. Free fetal DNA in maternal circulation: a potential prognostic marker for chromosomal abnormalities?
    Gerovassili A, Garner C, Nicolaides KH, Thein SL, Rees DC.
    Prenat Diagn; 2007 Feb 15; 27(2):104-10. PubMed ID: 17152117
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Peptide hormones in assessing fetal status.
    Spellacy WN.
    Clin Perinatol; 1974 Mar 15; 1(1):65-72. PubMed ID: 4470050
    [No Abstract] [Full Text] [Related]

  • 57. Parents' perspectives on the unforeseen finding of a fetal sex chromosomal aneuploidy.
    Pieters JJ, Kooper AJ, Eggink AJ, Verhaak CM, Otten BJ, Braat DD, Smits AP, van Leeuwen E.
    Prenat Diagn; 2011 Mar 15; 31(3):286-92. PubMed ID: 21294136
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.